Download PDF
Thromb Haemost 2000; 83(05): 799-800
DOI: 10.1055/s-0037-1613920
Letters to the Editor
Schattauer GmbH

Phenprocoumon-induced Hepatitis in a Patient with a Combined Hereditary Hemostatic Disorder

Irene Bux-Gewehr
1   From the Department of Hemostasis and Transfusion Medicine, Heinrich Heine University Medical Center, Düsseldorf, Germany
,
Rainer B. Zotz
1   From the Department of Hemostasis and Transfusion Medicine, Heinrich Heine University Medical Center, Düsseldorf, Germany
,
Rüdiger E. Scharf
1   From the Department of Hemostasis and Transfusion Medicine, Heinrich Heine University Medical Center, Düsseldorf, Germany
› Author Affiliations
Further Information

Publication History

Received 31 August 1999

Accepted after revision 14 January 2000

Publication Date:
08 December 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Woolley S, Burger HR, Zellweger U. Phenprocoumoninduzierte cholesta-tische Hepatitis. Dtsch Med Wschr 1995; 120: 1507-10.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 2 de Man RA, Wilson JHP, Schalm SW, ten Kate JW, van Leer E. Phenpro-coumoninduced hepatitis mimicking nonA, nonB hepatitis. J Hepatatol 1990; 11: 318-21.
    PubMedGoogle Scholar
  • 3 Slagboom G, Loeliger EA. Coumarin-Associated Hepatitis. Arch Intern Med 1980; 140: 1028-9.
    CrossrefPubMedGoogle Scholar
  • 4 Höhler T, Schnütgen M, Helmreich-Becker I, Mayet WJ, Mayer KHzum Büschenfelde. Druginduced hepatitis: a rare complication of oral anticoagulants. J Hepatol 1994; 21: 447-9.
    CrossrefPubMedGoogle Scholar
  • 5 Ehrenforth S, Scharrer I, Herrmann G. Phenprocoumoninduzierte nekroti-sierende Hepatitis. Dtsch Med Wschr 1995; 44: 1529-30.
    PubMedGoogle Scholar
  • 6 Den Boer W, Loeliger EA. Phenprocoumon-induced jaundice. Lancet 1976; i: 912.
    PubMedGoogle Scholar
  • 7 Hautekeete M, Holvoet J, Hubens H. Cytolytic hepatitis related to the oral anticoagulant phenprocoumon. Gastroenterol Clin Biol 1995; 19: 223-4.
    PubMedGoogle Scholar
  • 8 Wuillemin W, Zenhäusern R, Bernhard MC, Lämmle B. Phenprocoumon-induced hepatitis delaying precise diagnosis in a patient with activated protein C resistance due to factor V R506 Q mutation. Am J Med 1997; 103: 437-9.
    CrossrefPubMedGoogle Scholar
  • 9 Gondocs C, Szalay L, Balo-Banga JM, Feher J. Syncumar induced toxic liver damage. Orv Hetil 1990; 131: 1477-9.
    PubMedGoogle Scholar
  • 10 Ciorciaro C, Hartmann K, Stoller R, Kuhn M. Leberschäden durch Couma-rin-Antikoagulantien: Erfahrungen der IKS und der SANZ. Schweiz Med Wochenschr 1996; 126: 2109-13.
    PubMedGoogle Scholar
  • 11 Rehnqvist N. Intrahepatic Jaundice due to Warfarin therapy. Acta Med Scand 1978; 204: 335-6.
    PubMedGoogle Scholar
  • 12 Matsukawa R, Uemura S, Fukuchi S. Thrombosed St. Jude medical prothe-sis with drug induced hepatitis due to warfarin potassium – a case report. Nippon Kyobu Geka Gekkai Zasshi 1994; 42: 413-5.
    PubMedGoogle Scholar